Loading...
Derniers dépôts
-
Maya Hites, Clément Massonnaud, Eva Larranaga Lapique, Drifa Belhadi, Simon Jamard, et al.. Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial. Journal of Infection, 2024, 88 (3), pp.106120. ⟨10.1016/j.jinf.2024.106120⟩. ⟨hal-04577427⟩
-
Julien Lupo, Aurélie Truffot, Raphaële Germi, Anne-Karen Faure, Patrice Morand, et al.. Results of a French external quality assessment program for Epstein Barr virus serology. Diagnostic Microbiology and Infectious Disease, 2024, 109 (3), pp.116345. ⟨10.1016/j.diagmicrobio.2024.116345⟩. ⟨hal-04626877⟩